Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Blog
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cesarean section
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Companion diagnostic tests
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
See all tags

Meet MTRC at MEDICA 2026 in Düsseldorf, 16–19 November

MTRC will be attending MEDICA 2026 in Düsseldorf, Germany, on 16–19 November 2026 — one of the leading global platforms for medical technology and healthcare innovation.

MEDICA brings together international stakeholders from medicine, technology, industry, and healthcare to explore developments across clinical diagnostics and therapeutic technologies, digital health, integrated care, healthcare infrastructure, and medical technology.

The MTRC team, including Director Dr Oleg Borisenko, will be attending the event and available for meetings to discuss European market access, reimbursement, health economics, and evidence strategy for medical technologies.

If you are attending MEDICA 2026 and would like to discuss your specific market access or evidence needs in Europe, we invite you to arrange a meeting with our Senior Team in advance.

To schedule a meeting, contact us at [email protected].

We look forward to meeting you in Düsseldorf.

Tags
Services of MTRC

The latest related news

28
Sep 2026

Bi-weekly snapshot of market access and HEOR project work at MTRC – Edition 28th of September 2026

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of September 28th, we plan to work on 14 projects. Review the complete list of planned activities in this post.
Read more
18
Sep 2026

Meet MTRC at ISPOR Europe 2026: Booth #416

MTRC is joining ISPOR Europe 2026 in Vienna on 8–11 November — a great venue to discuss the evolving evidence requirements and reimbursement challenges shaping market access for medical technologies in Europe. Visit us at booth #416 to meet our team, or book a meeting in advance with MTRC Director Oleg Borisenko to discuss your specific European market access and evidence strategy needs.
Read more
14
Sep 2026

Bi-weekly snapshot of market access and HEOR project work at MTRC – Edition 14th of September 2026

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of September 14th, we plan to work on 15 projects. Review the complete list of planned activities in this post.
Read more
27
Aug 2026

MTRC Webinar: Europe’s Most Attractive MedTech Markets: The MTRC Reimbursement, Policy & HTA Attractiveness Index 2026

European countries differ substantially in the predictability, speed, evidence burden, and complexity of obtaining reimbursement and enabling routine hospital use of medical devices. This online seminar will present the methodology and key findings of the MTRC Reimbursement, Policy & HTA Attractiveness Index 2026, which compares 12 European markets across six dimensions and identifies Germany, Denmark, and Switzerland as the leading markets. It will explain how manufacturers can use the findings to support country prioritization, launch sequencing, evidence planning, and realistic time-to-revenue expectations, while recognizing that the results must be adapted to the characteristics of each technology. The seminar will be delivered by Oleg Borisenko, MD, PhD, on 27 August 2026 at 17:00 CET, is open only to medical technology industry representatives, and will not be recorded.
Read more